Current therapy for Charcot-Marie-Tooth disease

Current Treatment Options in Neurology

Volumn 7, Issue 1, 2005, Pages 23-31

  Grandis, Marina ^b   Shy, Michael E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CREATININE; EARLY GROWTH RESPONSE 2; GANGLIOSIDE INDUCED DIFFERENTIATION ASSOCIATED PROTEIN 1; IMMUNOGLOBULIN; MYELIN PROTEIN; MYELIN PROTEIN ZERO; NERVE PROTEIN; ONAPRISTONE; PERIPHERAL MYELIN PROTEIN 22; TETRACYCLINE; TRANSCRIPTION FACTOR; UBIQUINONE; UNCLASSIFIED DRUG; VIRUS VECTOR; VITAMIN;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BODY WEIGHT; CHROMOSOME 10; CHROMOSOME 11Q; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 8Q; CLINICAL TRIAL; DIET THERAPY; DISEASE CLASSIFICATION; DRUG SCREENING; EXERCISE; GENE DUPLICATION; GENE EXPRESSION; GENE LOCATION; GENE THERAPY; GENETIC LINKAGE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LINKAGE ANALYSIS; MUSCLE EXERCISE; NEUROPATHY; NONHUMAN; ONCOGENE C MYB; PHYSIOTHERAPY; POINT MUTATION; PREVALENCE; QUALITY OF LIFE; RECESSIVE GENE; VIRAL GENE DELIVERY SYSTEM;

EID: 13544257465     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-005-0003-5     Document Type: Article

References (20)

1. Dyck PJ, Chance P, Lebo R, Carney JA: Hereditary motor and sensory neuropathies. In Peripheral Neuropathy, 3rd Edition. Edited by Dyck PJ, Thomas PK, Griffin SW, et al.: Philadelphia: WB Saunders; 1993:1094-1136.
2. Matsunami N, Smith B, Ballard L, et al.: Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet 1992, 1: 76-179.
3. Lupski JR, Garcia CA: Molecular genetics and neuropathology of Charcot-Marie-Tooth disease type 1A. Brain Pathol 1992, 2:337-349.
4. Shy ME, Jani A, Krajewski K, et al.: Phenotypic clustering in MPZ mutations. Brain 2004, 127:371-384.
5. Berciano J, Combarros O: Hereditary neuropathies. Curr Opin Neurol 2003, 16:613-622.
6. Yoshihara T, Kanda F, Yamamoto M, et al.: A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot-Marie-Tooth disease type 1. J Neurol Sci 2001, 184:149-153.
7. Zuchner S, Mersiyanova IV, Muglia M, et al.: Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004, 36: 49-451.
8. Shy ME: Charcot-Marie-Tooth disease: an update. Curr Opin Neurol 2004, 17:579-585.
9. Nelis E, Erdem S, Van Den Bergh PY, et al.: Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology 2002, 59:1865-1872.
10. Chance PF, Alderson MK, Leppig KA, et al.: DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993, 72:143-151.
11. Vinci P, Perelli SI: Footdrop, foot rotation and plantar-flexor failure in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 2002, 83:513-516.
12. Mann RA, Missirian J: Pathophysiology of Charcot-Marie-Tooth disease. Clin Orthop 1988, 234: 21-228.
13. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM: Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1993, 74: 11-715.
14. Kilmer DD, McCrory MA, Wright NC, et al.: The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1994, 75:560-563.
15. Vinci P, Esposito C, Perelli SL, et al.: Overwork weakness in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 2003, 84:825-827.
16. Schwend RM, Drennan JC: Cavus foot deformity in children. J Am Acad Orthop Surg 2003, 11:201-211.
17. Sereda MW, Meyer zu Horste G, et al.: Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 2003, 9: 533-1537.
18. Koenig HL, Schumacher M, Ferzaz B, et al.: Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500-1503.
19. Passage E, Norreel JC, Noack-Fraissignes P, et al.: Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 2004, 10:396-401.
20. Perea J, Robertson A, Tolmachova T, et al.: C: Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 2001, 10: 007-1018.